Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

NCT03531931 · clinicaltrials.gov ↗

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety

Interventions

DRUG: Apatinib/Capecitatine

Sponsor

The First Affiliated Hospital of Xiamen University